Cargando…

Overexpression of COX-2 in oral squamous cell carcinoma patients undergoing chemoradiotherapy

AIMS AND OBJECTIVES: To evaluate the prognostic significance of cyclooxygenase-2 (COX-2) overexpression in oral squamous cell carcinoma (OSCC) patients undergoing chemoradiation therapy. Purpose of the study was to determine whether COX-2 could be used as a diagnostic and prognostic index in OSCC. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammad, Shadab, Ram, Hari, Gupta, Prem Narayan, Husain, Nuzhat, Bhatt, M.L.B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304216/ https://www.ncbi.nlm.nih.gov/pubmed/22442604 http://dx.doi.org/10.4103/0975-5950.85848

Ejemplares similares

Metastatic malignant melanoma of palate: A review of literature and report of an unusual case
por: Ram, Hari, et al.
Publicado: (2010)

Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation
por: Gupta, Seema, et al.
Publicado: (2016)

Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy
por: Gupta, Deepak, et al.
Publicado: (2011)

Concomitant-chemoradiotherapy-associated oral lesions in patients with oral squamous-cell carcinoma
por: Minhas, Sadia, et al.
Publicado: (2017)

VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma
por: Yoon, Mee Sun, et al.
Publicado: (2011)

Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma
por: Mishra, Sridhar, et al.
Publicado: (2020)

Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma
por: Khan, Huma, et al.
Publicado: (2014)

Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy
por: Yoshida, Ryoji, et al.
Publicado: (2020)

Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Tanaka, Keiichi, et al.
Publicado: (2020)

Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma
por: Nasry, Walaa Hamed Shaker, et al.
Publicado: (2018)

A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy
por: Wang, Peiliang, et al.
Publicado: (2021)

Cyclooxygenase-2 (COX-2) Expression in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma: An Immunohistochemical Study
por: Aparnadevi, Potsangbam, et al.
Publicado: (2022)

Detection of Survivin and COX-2 in Thyroid Carcinoma: Anaplastic Carcinoma Shows Overexpression of Nuclear Survivin and Low COX-2 Expression
por: Kim, Young A, et al.
Publicado: (2012)

COX-2 Overexpression in Schneiderian Papillomas
por: Suh, Jeffrey D., et al.
Publicado: (2020)

egfr overexpression in squamous cell carcinoma of the penis
por: Lavens, N., et al.
Publicado: (2010)

Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018)

Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma
por: Alam, Hunain, et al.
Publicado: (2012)

Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
por: Su, Po-Jung, et al.
Publicado: (2016)

Treatment outcomes in poor metabolizers of cytochrome P450 2A6 with concurrent chemoradiotherapy in locally advanced head- and neck-squamous cell carcinoma
por: Aggarwal, Deepa, et al.
Publicado: (2022)

Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018)

Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma
por: Harada, Hiroyuki, et al.
Publicado: (2013)

Successful treatment with nivolumab in a patient with unresectable oral squamous cell carcinoma following ineffective chemoradiotherapy
por: Sekido, Katsuhisa, et al.
Publicado: (2023)

Identification of Candida albicans using different culture media and its association in leukoplakia and oral squamous cell carcinoma
por: Gupta, Vivek, et al.
Publicado: (2019)

Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma
por: Roychoudhury, P, et al.
Publicado: (2007)

Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation
por: SUN, ZUJUN, et al.
Publicado: (2013)

Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Li, Long, et al.
Publicado: (2016)

Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
por: Ma, Hai-long, et al.
Publicado: (2017)

Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Xiao-Long, et al.
Publicado: (2020)

Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma
por: Hatano, Kiichi, et al.
Publicado: (2019)

Pulmonary tuberculosis as differential diagnosis of lung cancer
por: Bhatt, MLB, et al.
Publicado: (2012)

Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma
por: Roy, Nand Kishor, et al.
Publicado: (2019)

Expression of VEGF and Cox-2 in Patients with Esophageal Squamous Cell Carcinoma
por: Luz, Caio Cesar Floriano, et al.
Publicado: (2018)

Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma
por: JINNO, TEPPEI, et al.
Publicado: (2015)

Silver Binding Nucleolar Organizer Regions Dots in Oral Leukoplakia with Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An In Vivo Study
por: Mansoor Samadi, Fahad, et al.
Publicado: (2014)

The Modified Glasgow Prognostic Score Is an Independent Prognostic Factor in Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
por: Zhang, Peng, et al.
Publicado: (2014)

Impact of Chronic Obstruction Pulmonary Disease on Survival in Patients with Advanced Stage Lung Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy
por: Chiu, Kuo-Chin, et al.
Publicado: (2021)

Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma
por: Luo, Li-Ling, et al.
Publicado: (2017)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma
por: He, Hong-Lin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3134du4rlr43ik7fe4hqhv3o6d